TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10465324

Group type: EXPERIMENTAL
Intervention: Family-oriented lifestyle modification intervention (home visits, health curricula, group sessions)
Number of subjects: 1740

Group type: COMPARATOR
Intervention: Control group receiving only written information on individual risk profile
Number of subjects: 1740
Study: 7605863

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once a day for 2 weeks (Group 1)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once a day for 4 weeks (Group 2)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg twice a day for 2 weeks (Group 3)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg twice a day for 4 weeks (Group 4)
Number of subjects: 66
Study: 2194694

Group type: EXPERIMENTAL
Intervention: Conventional therapy combined with ticlopidine 250 mg b.i.d. (group C + T)
Number of subjects: 652
Study: 26517

Group type: EXPERIMENTAL
Intervention: 5 mg mequitazine twice daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 6983839

Group type: EXPERIMENTAL
Intervention: 2 mg/kg disoprofol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3 mg/kg disoprofol
Number of subjects: 10

Group type: COMPARATOR
Intervention: 4 mg/kg thiopentone
Number of subjects: 10

Group type: COMPARATOR
Intervention: 6 mg/kg thiopentone
Number of subjects: 10

Group type: COMPARATOR
Intervention: 1.5 mg/kg methohexitone
Number of subjects: 10
Study: 31201076

Group type: EXPERIMENTAL
Intervention: Quadriceps tendon (QT)
Number of subjects: 51
Study: 28683577

Group type: EXPERIMENTAL
Intervention: Identifying a support person
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Identifying multiple support persons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Engagement of social network
Number of subjects: 0
Study: 26459570

Group type: EXPERIMENTAL
Intervention: Astra Tech Osseospeed (S1)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Straumann Bone Level (S2)
Number of subjects: 64
Study: 25315167

Group type: EXPERIMENTAL
Intervention: Postpartum support film
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Postpartum support film with hotline service
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Hotline service alone
Number of subjects: 552

Group type: COMPARATOR
Intervention: Music CD (control)
Number of subjects: 552
Study: 22305678

Group type: EXPERIMENTAL
Intervention: Pneumovax (23-valent pneumococcal polysaccharide vaccine)
Number of subjects: 0
Study: 20819223

Group type: EXPERIMENTAL
Intervention: Manipulative therapy (manipulation and mobilization) in addition to usual medical care (UMC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual medical care (UMC)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Manipulative therapy (manipulation and mobilization)
Number of subjects: 150
Study: 17321820

Group type: EXPERIMENTAL
Intervention: Poststroke shoulder pain measured with BPI question 23 (11-point NRS)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Motor impairment measured with Fugl‐Meyer Assessment (FMA)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Activity limitation measured with Arm Motor Ability Test (AMAT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Activity limitation measured with FIM instrument
Number of subjects: 61
Study: 16222074

Group type: EXPERIMENTAL
Intervention: Repeated thermal stimuli on the same side for five daily sessions (Study 1)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Thermal stimuli restricted to one side for four daily sessions, then applied to the other side on the fifth session (Study 2)
Number of subjects: 22
Study: 14566490

Group type: EXPERIMENTAL
Intervention: Double-lumen tube (DLT)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Single-lumen tube (SLT) with intrathoracic CO2 insufflation at a rate of 0.5-1 l.min(-1) and sustained intrathoracic pressure at 6 mmHg
Number of subjects: 125
Study: 10101653

Group type: EXPERIMENTAL
Intervention: CT-guided intratumoral gene therapy (10 ml of a vector solution with replication-defective adenovirus containing wild-type p53 cDNA)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: CT-guided intratumoral gene therapy (2 ml aliquots injected into different tumor areas)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: CT-guided intratumoral gene therapy
Number of subjects: 6
Study: 7798494

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 24
Study: 2346975

Group type: EXPERIMENTAL
Intervention: Tarivid
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ciproxine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tarivid and Ciproxine
Number of subjects: 40
Study: 224958

Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate or oral fluphenazine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 29363027

Group type: COMPARATOR
Intervention: Tenapanor 10 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 50 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 150 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 450 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 900 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 3 mg q.d.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 10 mg q.d.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 30 mg q.d.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 100 mg q.d.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 15 mg b.i.d.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 30 mg b.i.d.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 30 mg t.i.d.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 60 mg b.i.d.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Escalating b.i.d. dose (30-90 mg total daily)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor 30 mg b.i.d. with psyllium
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tenapanor
Number of subjects: 23
Study: 27275351

Group type: EXPERIMENTAL
Intervention: 100 mg doxycycline once daily for 30 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: 20 mg doxycycline twice daily for 75 days
Number of subjects: 60
Study: 25642764

Group type: EXPERIMENTAL
Intervention: Bortezomib, thalidomide, and dexamethasone (VTD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thalidomide and dexamethasone (TD)
Number of subjects: 0
Study: 22972592

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249
Study: 20737820

Group type: EXPERIMENTAL
Intervention: Cash lottery incentive ($500 grand prize and five $100 prizes)
Number of subjects: 1150

Group type: COMPARATOR
Intervention: No incentive
Number of subjects: 1150

Group type: COMPARATOR
Intervention: Online newsletter advertisement (without incentive)
Number of subjects: 1150
Study: 18230350

Group type: EXPERIMENTAL
Intervention: Serum MT1-MMP levels
Number of subjects: 206

Group type: COMPARATOR
Intervention: Alendronate therapy
Number of subjects: 206
Study: 16641904

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (docetaxel 20 mg m(‐2) once weekly every 6 weeks + radiotherapy 2 Gy for 5 days a week, total 60 Gy)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Radiotherapy alone (2 Gy for 5 days a week, total 60 Gy)
Number of subjects: 108
Study: 12695290

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator (ICD)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Propranolol (beta-blockers)
Number of subjects: 86
Study: 11063789

Group type: EXPERIMENTAL
Intervention: m‐CPP (0.5 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 30
Study: 9176177

Group type: EXPERIMENTAL
Intervention: Anaerobic exercise training (ANT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aerobic exercise training (AET)
Number of subjects: 0
Study: 8449552

Group type: EXPERIMENTAL
Intervention: Trichloroethylene anaesthesia
Number of subjects: 10

Group type: COMPARATOR
Intervention: Epidural anaesthesia (Control)
Number of subjects: 10
Study: 3530933

Group type: EXPERIMENTAL
Intervention: 2 mg E2V
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 4 mg E2V
Number of subjects: 19
Study: 29357918

Group type: EXPERIMENTAL
Intervention: MUMentum Pregnancy (study 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: MUMentum Postnatal (study 2)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 50
Study: 27717766

Group type: COMPARATOR
Intervention: Cash incentives
Number of subjects: 800

Group type: COMPARATOR
Intervention: Charity incentives
Number of subjects: 800

Group type: COMPARATOR
Intervention: Fitbit tracker
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Control (no tracker or incentives)
Number of subjects: 800
Study: 24710666

Group type: EXPERIMENTAL
Intervention: Silent reading of syllables (Experiment 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hearing syllables (Experiment 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-pitched vocalization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-pitched vocalization
Number of subjects: 0
Study: 23268187

Group type: EXPERIMENTAL
Intervention: 72 hours of perioperative antimicrobial therapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: 120 hours of perioperative antimicrobial therapy
Number of subjects: 92
Study: 20427311

Group type: EXPERIMENTAL
Intervention: Audience response didactic
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Role play
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Human patient simulation
Number of subjects: 438

Group type: COMPARATOR
Intervention: Didactic (control)
Number of subjects: 438
Study: 18617385

Group type: EXPERIMENTAL
Intervention: Hyperbaric ropivacaine 15 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Hyperbaric ropivacaine 10 mg with sufentanil 5 micrograms
Number of subjects: 80
Study: 15723736

Group type: EXPERIMENTAL
Intervention: Handgrip strength (HG)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Subjective global assessment (SGA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prognostic nutritional index (PNI)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (hypertension and functional gastrointestinal disorders)
Number of subjects: 50
Study: 12559446

Group type: EXPERIMENTAL
Intervention: Jejunal pouch reconstruction
Number of subjects: 50

Group type: COMPARATOR
Intervention: Roux-en-Y reconstruction without pouch
Number of subjects: 50
Study: 10891645

Group type: EXPERIMENTAL
Intervention: Ethanol (0.7 g of ethanol/kg body weight)
Number of subjects: 0
Study: 9029249

Group type: EXPERIMENTAL
Intervention: Radionuclide imaging (RI)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Alkaline rinses
Number of subjects: 11

Group type: COMPARATOR
Intervention: Laparoscopy
Number of subjects: 11
Study: 1628013

Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic gastrostomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nasogastric feeding
Number of subjects: 40
Study: 6707381

Group type: EXPERIMENTAL
Intervention: 1.64 mg/kg amrinone
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: amrinone therapy
Number of subjects: 17

Group type: COMPARATOR
Intervention: placebo therapy
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: amrinone re-administration
Number of subjects: 17
Study: 30838534

Group type: EXPERIMENTAL
Intervention: Video teaching on obesity
Number of subjects: 949

Group type: COMPARATOR
Intervention: Control (no video teaching)
Number of subjects: 949
Study: 28669241

Group type: COMPARATOR
Intervention: Minimal level of intervention components
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Intense level of intervention components
Number of subjects: 256
Study: 27080598

Group type: EXPERIMENTAL
Intervention: Self-etching primer (SEP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional hydrophilic primer (Ortho-Solo®)
Number of subjects: 100
Study: 24946629

Group type: EXPERIMENTAL
Intervention: Comprehensive therapy (electroacupuncture, moxibustion, moving cupping)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Western medication (vitamin B1 and mecobalamine)
Number of subjects: 90
Study: 22215073

Group type: EXPERIMENTAL
Intervention: Transarterial chemoembolisation (TACE) with doxorubicin (75, 50, and 25 mg/m² based on bilirubin levels) and lipiodol, combined with continuous sorafenib 800 mg/day
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 15
Study: 20807874

Group type: EXPERIMENTAL
Intervention: Athletes with type 1 diabetes (ADM)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Subjects with type 1 diabetes
Number of subjects: 51
Study: 17392295

Group type: EXPERIMENTAL
Intervention: Mood stabilizer plus adjunctive antidepressant therapy
Number of subjects: 366

Group type: COMPARATOR
Intervention: Mood stabilizer plus matching placebo
Number of subjects: 366
Study: 16123205

Group type: EXPERIMENTAL
Intervention: Extravehicular activity (EVA) with denitrogenation procedures; initial cabin pressure 748 mmHg, final suit pressure approximately 295 or approximately 220 mmHg; no specific dosage or duration mentioned.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Measurements made in microgravity on days well separated from the EVA; control group not explicitly mentioned.
Number of subjects: 8
Study: 12351939

Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption (beer, 40 g/day for men, 30 g/day for women)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No alcohol consumption (control)
Number of subjects: 19
Study: 9990601

Group type: EXPERIMENTAL
Intervention: Medtronic 7219D
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Medtronic 7219C
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Medtronic 7223
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: CPI Ventak MINI
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: RV + IPP
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: RV
Number of subjects: 22
Study: 7560544

Group type: EXPERIMENTAL
Intervention: Org 3770
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 1580171

Group type: EXPERIMENTAL
Intervention: Glucose polymer beverage
Number of subjects: 76

Group type: COMPARATOR
Intervention: Glucose monomer beverage
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Capillary test
Number of subjects: 76
Study: 3894256

Group type: EXPERIMENTAL
Intervention: Chlorthalidone administered at 10h00
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chlorthalidone administered at 22h00
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo period
Number of subjects: 16
Study: 31136662

Group type: EXPERIMENTAL
Intervention: Yogurt (220 g/d for 24 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Milk (control group, 220 g/d for 24 weeks)
Number of subjects: 100
Study: 29140897

Group type: EXPERIMENTAL
Intervention: Slow, sedative music
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Fast, stimulative music
Number of subjects: 42

Group type: COMPARATOR
Intervention: No-music control
Number of subjects: 42
Study: 26352702

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral pain management program (4 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 46
Study: 23957897

Group type: EXPERIMENTAL
Intervention: Brief motivational interviewing (BMI) intervention delivered by dental practitioners
Number of subjects: 60

Group type: COMPARATOR
Intervention: Didactic control intervention
Number of subjects: 60
Study: 22794220

Group type: EXPERIMENTAL
Intervention: GIC placement immediately after MTA placement
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GIC placement after 1 day of temporization
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GIC placement after 7 days of temporization
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GIC placement with a wet cotton pellet
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GIC placement without a wet cotton pellet
Number of subjects: 50
Study: 20125104

Group type: EXPERIMENTAL
Intervention: LFHCCn-3 diet
Number of subjects: 29

Group type: COMPARATOR
Intervention: HSFA diet
Number of subjects: 29
Study: 18410686

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (8 treatment sessions, once a week, at individually selected points)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sham acupuncture (8 sessions, one per week, at non-acupuncture points using minimal puncture technique)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment (normal care)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verum or sham acupuncture (subsample for brain perfusion study)
Number of subjects: 0
Study: 15742431

Group type: EXPERIMENTAL
Intervention: LY333013 (50, 250, and 1000 mg)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 12556067

Group type: EXPERIMENTAL
Intervention: Lactate-buffered, single-chamber bag PDF (Lac-PDF)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Bicarbonate-buffered, double-chamber bag PDF (Bic-PDF)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Bicarbonate-buffered, double-chamber bag PDF (Bic Hi-PDF)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: LPS stimulation (100 ng/mL) after overnight dwells with Lac-PDF
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: LPS stimulation (100 ng/mL) after overnight dwells with Bic-PDF
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: LPS stimulation (100 ng/mL) after overnight dwells with Bic Hi-PDF
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: LPS stimulation (100 pg/mL) after overnight dwells with Lac-PDF
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: LPS stimulation (100 pg/mL) after overnight dwells with Bic-PDF
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: LPS stimulation (100 pg/mL) after overnight dwells with Bic Hi-PDF
Number of subjects: 8
Study: 9622469

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard treatment control
Number of subjects: 28
Study: 7937271

Group type: EXPERIMENTAL
Intervention: Bromfenac 25 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Bromfenac 50 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Bromfenac 100 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ibuprofen 200 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Fasted patients
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Fed patients
Number of subjects: 200
Study: 3276271

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (various drugs or drug combinations)
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics effective against oral microflora, especially anaerobic bacteria
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics against gram-negative aerobic bacteria
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Perioperative antibiotic administration
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Prolonged administration of antibiotics
Number of subjects: 547
Study: 28967980

Group type: EXPERIMENTAL
Intervention: Advancing Adolescents (8-week psychosocial intervention)
Number of subjects: 817

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 817
Study: 27855101

Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 387

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 387
Study: 25163749

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 23099796

Group type: EXPERIMENTAL
Intervention: Combination therapy with risedronate (35 mg weekly) and teriparatide (20 μg subcutaneously daily)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Teriparatide (20 μg subcutaneously daily)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Risedronate (35 mg weekly)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combination therapy with risedronate and teriparatide
Number of subjects: 29

Group type: COMPARATOR
Intervention: All therapies (combination, teriparatide, risedronate)
Number of subjects: 29
Study: 19837395

Group type: EXPERIMENTAL
Intervention: Laparoscopic TAPP herniorraphy
Number of subjects: 1795
Study: 18398097

Group type: COMPARATOR
Intervention: TAC (docetaxel at 75 mg/m², doxorubicin at 50 mg/m², cyclophosphamide at 500 mg/m²)
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: NX (vinorelbine at 25 mg/m² and capecitabine at 2000 mg/m²)
Number of subjects: 622

Group type: COMPARATOR
Intervention: TAC
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: NX
Number of subjects: 622
Study: 16518835

Group type: EXPERIMENTAL
Intervention: Discrete-choice contingent valuation (CV) survey
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parametric estimation of mean and median WTP
Number of subjects: 0
Study: 14607156

Group type: EXPERIMENTAL
Intervention: Moderately imageable words mixed with high image nouns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderately imageable words mixed with low image nouns
Number of subjects: 0
Study: 10879332

Group type: EXPERIMENTAL
Intervention: Intravenous 10% invert sugar
Number of subjects: 32

Group type: COMPARATOR
Intervention: Lactated Ringer's solution with 5% dextrose (D5LR)
Number of subjects: 32
Study: 8880694

Group type: EXPERIMENTAL
Intervention: Propentofylline (HWA 285)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8401245

Group type: EXPERIMENTAL
Intervention: Behavioral strategies group (n = 42)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Behavioral strategies with instruction group (n = 41)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Compliance group (n = 32)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Attention control group (n = 41)
Number of subjects: 156
Study: 3517537

Group type: EXPERIMENTAL
Intervention: Zinc oxide impregnated adhesive plaster (zinc tape)
Number of subjects: 1483

Group type: COMPARATOR
Intervention: Conventional antiseptic soaked gauze dressings (control)
Number of subjects: 1483
Study: 30326932

Group type: EXPERIMENTAL
Intervention: well-being therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: control condition
Number of subjects: 30